Vantia Therapeutics
Latest round
- Series B
Last raised
- Jan 2015
Total raised
- $63M
Investors
- 3
About Vantia Therapeutics
Vantia Therapeutics is a biotechnology company focused on developing innovative therapeutics for patients in need.Founded in 2008, Vantia Therapeutics is a biotech firm headquartered in Southampton, UK. The company focuses on the development of novel drugs and has undergone strategic pivots in its operational approach.Vantia Therapeutics offers a range of innovative therapeutics aimed at addressing unmet medical needs. Their core offerings focus on drug development solutions for various diseases, providing advanced solutions for medical challenges.Vantia Therapeutics generates revenue through a model based on strategic partnerships and collaborations with pharmaceutical firms. Clients engage in long-term agreements to access Vantia's proprietary drug development services and solutions.Vantia Therapeutics plans to launch new therapeutics aimed at addressing specific diseases by 2024, enhancing its product portfolio. The company also intends to expand its reach into the Asian markets, particularly targeting China and Japan for growth opportunities by 2025.00 million will support these initiatives, facilitating research and development efforts to bring new products to market.
Who invested in Vantia Therapeutics
3 investors across 6 rounds
See all investors in Vantia Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vantia Therapeutics
Who invested in Vantia Therapeutics?
Vantia Therapeutics has 3 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vantia Therapeutics raised?
Vantia Therapeutics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Vantia Therapeutics last raise money?
Vantia Therapeutics's most recent round on record is a Series B, in Jan 2015.
What does Vantia Therapeutics do?
Vantia Therapeutics is a biotechnology company focused on developing innovative therapeutics for patients in need.
Where is Vantia Therapeutics headquartered?
Vantia Therapeutics is headquartered in Southampton, UK.
Which VCs invest in companies like Vantia Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Vantia Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Vantia Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.